Decoding the Genetic Networks of Red Blood Cells: A Breakthrough for Understanding Complex Disease
For decades, scientists have known that most traits, especially those related to disease, aren’t dictated by single genes, but by a complex interplay of thousands. while genome-wide association studies (GWAS) have identified numerous genetic variants linked to disease, understanding why these variants matter has remained a significant challenge. Now, a groundbreaking study led by researchers at Gladstone Institutes and Stanford University is offering a powerful new approach to unraveling these intricate genetic networks, starting with a deep dive into the biology of red blood cells.
This research, published in Nature on december 10, 2025, doesn’t just identify associations; it begins to illuminate the causal pathways connecting genetic variation to biological function and ultimately, to disease.This is a critical step forward in translating genomic information into tangible benefits for human health.
The Challenge of Complex Traits: Beyond Association to Understanding
“Even with extensive genetic studies, a huge gap remains in our understanding of disease biology at a genetic level,” explains Dr. Mineto Ota, the study’s first author and a postdoctoral scholar. “We know that many variants are associated with disease, but we don’t understand why.” dr. Ota aptly compares the current state of knowledge to having a map with a clear start and finish, but no roads to guide the journey.
Dr. Jonathan Pritchard, a professor of Biology and Genetics at Stanford and co-leader of the study, emphasizes the need for a systems-level perspective. “To understand complex traits, we really need to focus on the network. How do we think about biology when thousands and thousands of genes, with many different functions, are all affecting a trait?”
A novel Approach: Combining Cellular Experiments with Population-Scale Data
The researchers tackled this network problem by ingeniously combining data from two powerful sources. First, they leveraged a pre-existing dataset generated by MIT researchers who systematically “switched off” each gene in a human leukemia cell line, meticulously tracking the resulting changes in genetic activity. this provided a detailed understanding of gene function at the cellular level.
Crucially, this cellular data was then integrated with genomic sequences from over 500,000 individuals in the UK Biobank, a vast repository of health and genetic information. Dr. Ota’s team searched for individuals carrying genetic mutations that mimicked the effects of gene “knockout” observed in the cell line experiments - specifically, mutations that reduced gene function and altered red blood cell characteristics.
This innovative approach allowed the team to construct a remarkably detailed map of the gene networks governing red blood cell traits, revealing not just the starting point and destination, but the complex web of interactions in between.
Uncovering Key Genetic Players: The Case of SUPT5H
the research yielded specific insights into the function of individual genes. for example, the team identified SUPT5H, a gene previously linked to beta thalassemia (a blood disorder causing anemia), as a central regulator of multiple critical blood cell processes.
“SUPT5H regulates all three main pathways that affect hemoglobin,” explains Dr. Pritchard. “It activates hemoglobin synthesis, slows down the cell cycle, and slows down autophagy, which together have a synergistic effect.” This demonstrates how a single gene can exert influence across multiple biological pathways, contributing to the complexity of disease.
Implications for Immunology and Beyond: A Platform for Future discovery
The importance of this study extends far beyond red blood cell biology. While the team successfully mapped the genetic networks influencing blood cell behaviour, the true breakthrough lies in the methodology itself. This strategy can now be applied to other human cell types, unlocking the molecular patterns driving a wide range of diseases.
For the Marson lab,which specializes in T cells and the immune system,the potential is particularly exciting. “The genetic burden associated with many autoimmune diseases, immune deficiencies, and allergies are overwhelmingly linked to T cells,” says Dr. Alexander Marson. “We look forward to developing additional detailed maps that will help us really understand the genetic architecture behind these immune-mediated diseases.”
A New Era of Precision Medicine
This research represents a significant leap forward in our ability to understand the genetic basis of complex diseases.By moving beyond simple associations and delving into the intricate networks that govern cellular function, scientists are paving the way for more targeted and effective therapies. This approach promises to reshape both basic biology and drug development, ultimately leading to a new era of precision medicine.
Study Citation: Ota, M., Spence, J., Zeng, T., Dann, E., Milind, N., Marson, A., & Pritchard, J. (2025). Causal modeling of gene effects from regulators to programs to traits. Nature.
Related reading